Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.

Neuropsychobiology - 1 Jan 2014

Takahashi Hitoshi, Yoshida Keizo, Higuchi Hisashi, Kamata Mitsuhiro, Inoue Kazuyuki, Suzuki Toshio, Ishigooka Jun

Abstract excerpt

BACKGROUND: Polymorphisms in the glucocorticoid receptors (GRs) have been widely studied with rather less emphasis on relating their differences with possible pharmacological treatment outcomes. The purpose of this study was to investigate whether Bcl1 polymorphisms of GRs are associated with the antidepressant effect of milnacipran, a serotonin noradrenaline reuptake inhibitor (SNRI), and fluvoxamine, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Cyclin D1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclopropanes

Share to Depressive Disorder, Major

Share to Fluvoxamine

Share to Receptors, Glucocorticoid

Share to Selective Serotonin Reuptake Inhibitors

Share to Severity of Illness Index

Source

Identifiers

PMID: 25358426
DOI: 10.1159/000365517

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.PMID 25358426Read ↗

Glucocorticoid Receptor Genetic Variants and Response to Fluoxetine in Major Depressive Disorder.Semantic proximity Read ↗

The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study.Semantic proximity Read ↗

TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.Semantic proximity Read ↗

Association between the serotonin 1A receptor C(-1019)G polymorphism and major depressive disorder in the northern Han ethnic group in China.Semantic proximity Read ↗

Association between NR3C1 rs41423247 polymorphism and depressionSemantic proximity Read ↗

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.Semantic proximity Read ↗

Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.Semantic proximity Read ↗

Association of NPSR1 rs324981 polymorphism and treatment response to antidepressants in Chinese Han population with generalized anxiety disorder.Semantic proximity Read ↗

Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.Semantic proximity Read ↗

Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.Semantic proximity Read ↗

MDR1 gene polymorphism in Japanese patients with schizophrenia and mood disorders including depression.Semantic proximity Read ↗

Does G2677T Polymorphism of the MDR1 Gene Make a Difference in the Therapeutic Response to Paroxetine in Depressed Patients in a Slovakian Population?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.